您的浏览器禁用了JavaScript(一种计算机语言,用以实现您与网页的交互),请解除该禁用,或者联系我们。[美股财报]:GoodRx Holdings Inc-A 2024年度报告 - 发现报告

GoodRx Holdings Inc-A 2024年度报告

2025-04-23美股财报表***
GoodRx Holdings Inc-A 2024年度报告

Annual Report GoodRx Holdings, Inc. GoodRx makes it easyfor people to save timeand money when fillingmedications. “Using GoodRx reallywas a weight lifted offme. I felt like someonewas there to help me.” Monica GonzalezGoodRx consumer Forward-Looking Statement: This Annual Report contains forward-looking statements within the meaning of thePrivate Securities Litigation Reform Act of 1995. All statements contained in thisAnnual Report that do not relate to matters of historical fact should be consideredforward-looking statements, including, without limitation, statements regarding ourfuture results of operations and financial position, industry and business trends, ourvalue proposition, our collaborations and partnerships with third parties, including ourintegrated savings program and anticipated expansion to non-covered brands, ourdirect contracting approach with select pharmacies, enhancing shareholder value,our business strategy, our plans, market opportunity and growth, and our objectivesfor future operations. These statements are neither promises nor guarantees, butinvolve known and unknown risks, uncertainties, and other important factors that maycause our actual results, performance, or achievements to be materially differentfrom any future results, performance or achievements expressed or implied by theforward-looking statements, including the important factors discussed in Part I, Item1A, “Risk Factors” of our Annual Report on Form 10-K for the year ended December31, 2024 included herewith, and our other filings with the SEC. These factors couldcause actual results to differ materially from those indicated by the forward-lookingstatements made in this Annual Report. Any such forward-looking statementsrepresent management’s estimates as of the date of this Annual Report. While wemay elect to update such forward-looking statements at some point in the future, wedisclaim any obligation to do so, even if subsequent events cause our views to change. To our valued shareholders: At GoodRx, we are proud of the role we play in making medications moreaccessible and affordable for millions of Americans. Uniquely situated atthe center of the pharmacy ecosystem, we connect consumers, healthcareprofessionals, pharmacies, pharmaceutical manufacturers, and pharmacybenefit managers to make saving on medications simpler. We strive to reducefriction and improve access, making it easy for people to save time and moneywhen filling medications, so they can get the care they deserve. As a valuablecomplement to insurance, we aim to fill in the coverage gaps and solve benefitdesign challenges that consumers are facing. Fiscal Year 2024Highlights Saved by consumerscumulatively1~$85B We believe our solutions have never been more needed as healthcare is morecomplex, friction-filled, and expensive. Benefit design is more restrictive withfewer drugs on formulary, more utilization management, and higher costs.Pharmaceutical manufacturers face barriers in getting their brand medications toconsumers. Retail pharmacy economics are distorted with rising reimbursementpressure and operational costs. All the while, more of the cost burden is shiftingto the consumer. ~$17B Saved by consumersin 20242 ~30M In 2024, we made significant progress in helping consumers, healthcareprofessionals, and other constituents in the pharmacy ecosystem solvevarious pain points: Consumers saved ontheir prescriptions usingGoodRx in 20243 •Consumerscame to GoodRx to save time and money on their medications.Nearly thirty million consumers used GoodRx in 2024, which was almostfive million more than 2023. We served as a valuable complement to healthinsurance. We estimate that over 90% of our users had insurance⁵ and stillneeded GoodRx because of the increasing costs and narrowing coverageof their plan. We delivered significant savings. In 2024, GoodRx userssaved 83% on retail prescription prices, which resulted in $17 billion inmedication savings². 1M+ Unique healthcareprofessionals (HCPs)visited GoodRx in 20244 •Healthcare professionalsused GoodRx to get their patients on themedications they need and save precious time. Over one millionhealthcare professionals used GoodRx in 2024. We served as a trustedpartner, helping patients adhere to treatment plans and receive the carethey deserve. •Pharmaciesworked with GoodRx to acquire new consumers, reducefriction at the counter, and improve their profitability. GoodRx partneredclosely with pharmacies to drive sustainable value and to help solvechallenges they faced around lower reimbursement and higher storecosts. Our flexible contracting model supported pharmacies in theirability to merchandise. •Pharmaceutical manufacturersworked with GoodRx to make their brandmedications available to more consumers. In 2024, we partnered withover 200 brands on the GoodRx platform, which was up from 150 in 2023.We helped pharma manufacturers serve more patients and grow theirrevenue through our integrated acce